1. Home
  2. ALLO vs CAN Comparison

ALLO vs CAN Comparison

Compare ALLO & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.44

Market Cap

539.4M

Sector

Health Care

ML Signal

HOLD

CAN

Canaan Inc.

HOLD

Current Price

$0.45

Market Cap

486.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
CAN
Founded
2017
2013
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
539.4M
486.0M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
ALLO
CAN
Price
$2.44
$0.45
Analyst Decision
Buy
Strong Buy
Analyst Count
11
8
Target Price
$8.40
$3.09
AVG Volume (30 Days)
4.3M
9.1M
Earning Date
03-12-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
34.09
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$140,929.80
$63.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$0.43
52 Week High
$2.80
$2.22

Technical Indicators

Market Signals
Indicator
ALLO
CAN
Relative Strength Index (RSI) 55.11 37.21
Support Level $2.20 $0.43
Resistance Level $2.76 $0.55
Average True Range (ATR) 0.20 0.03
MACD -0.06 0.00
Stochastic Oscillator 56.06 16.10

Price Performance

Historical Comparison
ALLO
CAN

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

Share on Social Networks: